RuVaCare

N/A

Report date: 2025/03/20 09:14:23

Base Information

Drug NameRuVaCare
Drug Alias Nametumor antigen presenting cell-based vaccine (Theralase Technologies)
ClassificationCell and gene therapy > Cell therapyVaccines > Application > Therapeutic vaccineBiologics > Antigen > Tumor antigen
Mechanisms of ActionT lymphocytes stimulants
TargetsNot applicable
Therapy Area/IndicationsColorectal NeoplasmsGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTheralase Technologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesTheralase Technologies Inc
Inactive CompaniesN/A
Active IndicationsColorectal NeoplasmsGlioblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A